Biological characterization of folate-decorated biodegradable polymer-platinum(II) complex micelles

Molecular Pharmaceutics

Volumn 9, Issue 11, 2012, Pages 3200-3208

  Wang, Rui ^a,b   Hu, Xiuli ^a   Wu, Sai ^c   Xiao, Haihua ^a,b   Cai, Haidong ^d   Xie, Zhigang ^a   Huang, Yubin ^a   Jing, Xiabin ^a  

^a CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c JILIN UNIVERSITY   (China)

^d CHANGCHUN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

biodegradable; folic acid targeting; multifunctional micelles; oxaliplatin; polymer platinum complex

Indexed keywords

ANTINEOPLASTIC AGENT; COPOLYMER; DIAMINOCYCLOHEXANE PLATINUM; DRUG CARRIER; FOLIC ACID; OXALIPLATIN; PLATINUM COMPLEX; POLY(ETHYLENE GLYCOL) BLOCK POLY(LEVO LACTIDE CO 2 METHYL 2 CARBOXYLPROPYLENE CARBONATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; ATOMIC ABSORPTION; ATOMIC EMISSION SPECTROMETRY; BIODEGRADABILITY; CANCER CELL CULTURE; CELL STRAIN MCF 7; CHEMICAL STRUCTURE; CIRCULATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MICELLE; MOUSE; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; TUMOR CELL; TUMOR VOLUME;

ANIMALS; BREAST NEOPLASMS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; FOLIC ACID; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; MASS SPECTROMETRY; MICE; MICELLES; ORGANOPLATINUM COMPOUNDS; OVARIAN NEOPLASMS; POLYMERS; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84868536613     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp3002914     Document Type: Article

References (21)

1. Cicin, I.; Saip, P.; Eralp, Y.; Selam, M.; Topuz, S.; Ozluk, Y.; Aydin, Y.; Topuz, E. Ovarian carcinosarcomas: Clinicopathological prognostic factors and evaluation of chemotherapy regimens con taining platinum Gynecol. Oncol. 2008, 208, 136-140
2. Wheate, N. J.; Walker, S.; Craig, G. E.; Oun, R. The status of platinum anticancer drugs in the clinic and in clinical trials Dalton Trans. 2010, 39, 8113-8127
3. Wang, D.; Lippard, S. J. Cellular processing of platinum anticancer drugs Nat. Rev. Drug Discovery 2005, 4, 307-320
4. Ibrahim, A.; Hirschfeld, S.; Cohen, M. H.; Griebel, D. J.; Williams, G. A.; Pazdur, R. FDA drug approval summaries: oxaliplatin Oncologist 2004, 9, 8-12
5. Extra, J. N.; Espie, M.; Calvo, F.; Ferme, C.; Mignot, L.; Marty, M. Phase I study of oxaliplatin in patients with advanced cancer Cancer Chemother. Pharmacol. 1990, 25, 299-303
6. Xiao, H. H.; Qi, R. G.; Liu, S.; Hu, X. L.; Duan, T. C.; Zheng, Y. H.; Huang, Y. B.; Jing, X. B. Biodegradable polymer-cisplatin(IV) conjugate as a pro-drug of cisplatin(II) Biomaterials 2011, 32, 7732-7739
7. Tong, R.; Cheng, J. J. Anticancer polymeric nanomedicines Polym. Rev. 2007, 47, 345-381
8. Huynh, V. T.; Quek, J. Y.; de Souza, P. L.; Stenzel, M. H. Block Copolymer Micelles with Pendant Bifunctional Chelator for Platinum Drugs: Effect of Spacer Length on the Viability of Tumor Cells Biomacromolecules 2012, 13, 1010-1023
9. Wang, Y. M.; Sato, H.; Adachi, I.; Horikoshi, I. Optimization of the formulation design of chitosan microspheres containing cisplatin J. Pharm. Sci. 1996, 85, 1204-1210
10. Tomalia, D. A.; Reyna, L. A.; Svenson, S. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging Biochem. Soc. Trans. 2007, 35, 61-67
11. Lin, X.; Zhang, Q.; Rice, J. R.; Stewart, D. R.; Nowotnik, D. P.; Howell, S. B. Improved targeting of platinum chemotherapeutics: The antitumour activity of the HPMA copolymer platinum agent AP5280 in murine tumour models Eur. J. Cancer 2004, 40, 291-297
12. Caldwell, G.; Neuse, E. W.; van Rensburg, C. E. J. Cytotoxicity of selected water-soluble polymer-cis-diaminedichloroplatinum(II) conjugates against the human HeLa cancer cell line J. Inorg. Organomet. Polym. 1997, 7, 217-231
13. Cabral, H.; Nishiyama, N.; Kataoka, K. Optimization of (1,2-diamino-cyclohexane)platinum(II)-loaded polymeric micelles directed to improved tumor targeting and enhanced antitumor activity J. Controlled Release 2007, 121, 146-155
14. Xiao, H. H.; Zhou, D. F.; Liu, S.; Zheng, Y. H.; Huang, Y. B.; Jing, X. B. A complex of cyclohexane-1,2-diaminoplatinum with an amphiphilic biodegradable polymer with pendant carboxyl groups Acta Biomater. 2012, 8, 1859-1868
15. Cabral, H.; Matsumoto, Y.; Mizuno, K.; Chen, Q.; Murakami, M.; Kimura, M.; Terada, Y.; Kano, M. R.; Miyazono, K.; Uesaka, M.; Nishiyama, N.; Kataoka, K. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size Nat. Nanotechnol. 2011, 6, 815-823
16. Zhou, Y.; Wang, H.; Wang, C. X.; Li, Y. S.; Lu, W. F.; Chen, S. F.; Luo, J. D.; Jiang, Y. N.; Chen, J. H. Receptor-Mediated, Tumor-Targeted Gene Delivery Using Folate- Terminated Polyrotaxanes Mol. Pharmaceutics 2012, 9, 1067-1076
17. Hu, X. L.; Wang, R.; Yue, J.; Liu, S.; Xie, Z. G.; Jing, X. B. Targeting and anti-tumor effect of folic acid-labeled polymer-Doxorubicin conjugates with pH-sensitive hydrazone linker J. Mater. Chem. 2012, 10.1039/c2jm31130e
18. Vollano, J. F.; Al-Baker, S.; Dabrowiak, J. C.; Schurig, J. E. Comparative antitumor studies on platinum(II) and platinum(IV) complexes containing 1,2-diaminocyclohexane J. Med. Chem. 1987, 30, 716-719
19. Ma, P. A.; Liu, S.; Huang, Y. B.; Chen, X. S.; Zhang, L. P.; Jing, X. B. Lactose mediated liver-targeting effect observed by ex vivo imaging technology Biomaterials 2010, 31, 2646-2654
20. Yue, J.; Liu, S.; Wang, R.; Hu, X. L.; Xie, Z. G.; Huang, Y. B.; Jing, X. B. Transferrin-conjugated micelles: enhanced accumulation and antitumor effect for transferrin-receptor-overexpressing cancer models Mol. Pharmaceutics 2012, 9, 1919-1931
21. Hu, X. L.; Liu, S.; Huang, Y. B.; Chen, X. S.; Jing, X. B. Biodegradable Block Copolymer-Doxorubicin Conjugates via Different Linkages: Preparation, Characterization, and In Vitro Evaluation Biomacromolecules 2010, 11, 2094-2102